These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1224 related items for PubMed ID: 30430854

  • 1. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
    Xu H, Hu L, Wei X, Niu J, Gao Y, He J, Hou J.
    J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Significance of preoperative systemic immune-inflammation (SII) in predicting postoperative systemic inflammatory response syndrome after percutaneous nephrolithotomy.
    Peng C, Li J, Xu G, Jin J, Chen J, Pan S.
    Urolithiasis; 2021 Dec; 49(6):513-519. PubMed ID: 33835228
    [Abstract] [Full Text] [Related]

  • 4. Platelet-to-Lymphocyte Ratio: A New Factor for Predicting Systemic Inflammatory Response Syndrome after Percutaneous Nephrolithotomy.
    Cetinkaya M, Buldu I, Kurt O, Inan R.
    Urol J; 2017 Aug 29; 14(5):4089-4093. PubMed ID: 28853103
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.
    Liu Z, Jin K, Guo M, Long J, Liu L, Liu C, Xu J, Ni Q, Luo G, Yu X.
    Ann Surg Oncol; 2017 Feb 29; 24(2):561-568. PubMed ID: 27650825
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk factors for systemic inflammatory response syndrome after percutaneous nephrolithotomy.
    He Z, Tang F, Lei H, Chen Y, Zeng G.
    Prog Urol; 2018 Oct 29; 28(12):582-587. PubMed ID: 30301521
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of CD3+ cells and interleukin 2 receptor in systemic inflammatory response syndrome after percutaneous nephrolithotomy.
    He Y, Xia D, Tong Y, Shang H, Liu X, Peng E, Huang Q, Tang K, Chen Z.
    Front Immunol; 2022 Oct 29; 13():1017219. PubMed ID: 36505430
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Machine learning models to predict systemic inflammatory response syndrome after percutaneous nephrolithotomy.
    Zhang T, Zhu L, Wang X, Zhang X, Wang Z, Xu S, Jiao W.
    BMC Urol; 2024 Jul 08; 24(1):140. PubMed ID: 38972999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.